A Study of CriPec® Docetaxel Given to Patients With Solid Tumours
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The goal of this Phase1 clinical research study is to find the highest safe dose of CriPec®
docetaxel that can be given in the treatment of patients with solid tumours.